Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments

Autor: Ros, J., Matito, J., Villacampa, G., Comas, R., Garcia, A., Martini, G., Baraibar, I., Saoudi, N., Salvà, F., Martin, Á., Antista, M., Toledo, R., Martinelli, E., Pietrantonio, F., Boccaccino, A., Cremolini, C., Dienstmann, R., Tabernero, J., Vivancos, A., Elez, E.

Publikováno v: In Annals of Oncology June 2023 34(6):543-552

288 Clinical study of Netherton syndrome treated topically with a Staphylococcus epidermidis strain expressing recombinant human LEKTI-D6 (ATR12-351)

Autor: Spellman, M.C., Salva, F., Mootien, S., Leger, R., Whitfill, T.M.

Publikováno v: In Journal of Investigative Dermatology August 2024 144(8) Supplement:S50-S50

Cetuximab rechallenge in RAS, BRAF, EGFR-ECD wild type metastatic colorectal cancer (mCRC) patients treated with anti-EGFR therapies in first line: The CITRIC study

Autor: Vivas, CS, Salva, F, Fernandez-Rodriguez, C, Orduna, VA, Losa, F, Paez, D, Vidal, J, Salud, A, Fernandez, PR, Aguilera, MS, Tarazona, N, Hernandez-Yague, X, Romero, LL, Garcia-Carbonero, R, Rivera, F, Gallego, RA, Bellosillo, B, Montagut, C

Publikováno v: Annals of Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::6059e4f76a52a3c03290431571a88cc5
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7129

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

PD-12 Characterization of best responder patients to oxaliplatin rechallenge in patients with refractory metastatic colorectal cancer (mCRC)

Autor: Salva, F., Garcia, A., Saoudi, N., Baraibar, I., Ros, J., Comas, R., Ruiz, F., Rezqallah, A., Cuadra, J., Dientsmann, R., Tabernero, J., Elez, E.

Publikováno v: In Annals of Oncology June 2022 33 Supplement 4:S243-S244